Pharma Blog Watch

Rethinking R&D Reorganization (QDIS Blog)
In his blog, Ed Vawter writes about recent news that Roche is reorganizing its R&D operations. "I've seen this before and I don't have much faith in these 'reorganizations'," he writes.

"GlaxoSmithkline reorganized their research into seven Centres of Excellence for Drug Discovery years ago, and I don't know that it has increased their overall productivity," he writes. "It may get more drugs into development, but the more important issue is making sure the ones that do go into development have the greatest possible probability of success."

"Inevitably, these sorts of moves don't make major contributions to the bottom line and sometimes actually make matters worse."